Sunday, November 28, 2021


Indians more resistant to Covid

Suggest two studies which have explored the factors behind low mortality rate in India

Bharat Biotech’s Covaxin to boost immune response with ViroVax adjuvant  

Hyderabad-headquartered company is currently conducting Phase II human trials of Covaxin after receiving Drug Controller General of India nod

Latest News

- Advertisement -